狼疮性肾炎——特异的免疫抑制调节及治疗展望

[1] The Cd40 ligand[J] . Iqbal S. Grewal,Richard A. Flavell.Immunologic Research . 1997 (1)

[2] Therapeutic potential for blockade of the CD40 ligand, gp39[J] . Janet E. Buhlmann,Randolph J. Noelle.Journal of Clinical Immunology . 1996 (2)

[3] Syste mic lupus with nephritis : A longter m study. Ca meron J S , Turner D R , Ogg C S et al. O J Med . 1979

[4] Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Dooley MA, Hogan S, Jennette C et al. Kidney International . 1997

[5] Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Ciruelo E, De la Cruz J, Lopex I et al. Arthritis and Rheumatism . 1996

[6] Antibodies to DNA. Hahm BH. The New England Journal of Medicine . 1998

[1] The Cd40 ligand[J] . Iqbal S. Grewal,Richard A. Flavell.Immunologic Research . 1997 (1)

[2] Therapeutic potential for blockade of the CD40 ligand, gp39[J] . Janet E. Buhlmann,Randolph J. Noelle.Journal of Clinical Immunology . 1996 (2)

[3] Syste mic lupus with nephritis : A longter m study. Ca meron J S , Turner D R , Ogg C S et al. O J Med . 1979

[4] Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Dooley MA, Hogan S, Jennette C et al. Kidney International . 1997

[5] Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Ciruelo E, De la Cruz J, Lopex I et al. Arthritis and Rheumatism . 1996

[6] Antibodies to DNA. Hahm BH. The New England Journal of Medicine . 1998